stoxline Quote Chart Rank Option Currency Glossary
  
Cybin Inc. (CYBN)
0.366  -0.014 (-3.68%)    04-12 16:00
Open: 0.3822
High: 0.3925
Volume: 7,320,751
  
Pre. Close: 0.38
Low: 0.3557
Market Cap: 161(M)
Technical analysis
2024-04-12 4:48:36 PM
Short term     
Mid term     
Targets 6-month :  0.53 1-year :  0.6
Resists First :  0.45 Second :  0.52
Pivot price 0.41
Supports First :  0.35 Second :  0.29
MAs MA(5) :  0.4 MA(20) :  0.42
MA(100) :  0.39 MA(250) :  0.39
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  9.6 D(3) :  23
RSI RSI(14): 40.4
52-week High :  0.73 Low :  0.2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CYBN ] has closed below the lower bollinger band by 8.9%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.39 - 0.4 0.4 - 0.4
Low: 0.35 - 0.35 0.35 - 0.36
Close: 0.36 - 0.37 0.37 - 0.37
Company Description

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Headline News

Wed, 10 Apr 2024
Cybin Inc. to Present at Healthcare Investor Conference - TipRanks.com - TipRanks

Wed, 10 Apr 2024
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Yahoo Finance

Thu, 21 Mar 2024
Cybin Raises $150M to Advance Psychedelic Therapy for Depression - HIT Consultant

Tue, 19 Mar 2024
Cybin, Inc. Shines at Dallas Investor Event - TipRanks.com - TipRanks

Tue, 19 Mar 2024
Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million - Business Wire

Thu, 14 Mar 2024
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 406 (M)
Shares Float 352 (M)
Held by Insiders 12 (%)
Held by Institutions 6.8 (%)
Shares Short 12,400 (K)
Shares Short P.Month 10,770 (K)
Stock Financials
EPS -0.19
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.18
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -51.7 %
Return on Equity (ttm) -90.4 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.13
Qtrly Earnings Growth 0 %
Operating Cash Flow -44 (M)
Levered Free Cash Flow -25 (M)
Stock Valuations
PE Ratio -2.04
PEG Ratio 0
Price to Book value 1.92
Price to Sales 0
Price to Cash Flow -3.4
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android